Dr. Hehenberger has served as Chief Executive Officer of Lyfebulb, Inc., a patient engagement platform, since January 2014. From 2011 to 2013, Dr. Hehenberger served in various roles at Coronado Biosciences, Inc. (now Fortress Biotech, Inc.), including Senior Vice President of Scientific Affairs and, most recently, Chief Medical Officer. Dr. ... Read More
23
Sep2022
Mr. Maroun has served on Aadi’s board of directors since February 2017. Since June 2014, Mr. Maroun has served as Partner, General Counsel at Frazier Healthcare Partners, a private equity and venture capital firm. Prior to joining Frazier, Mr. Maroun was Senior Vice President and General Counsel of Aptalis Pharma ... Read More
21
Sep2022
Emma Reeve served as Senior Vice President and Chief Financial Officer of Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, from October 2017 to July 2021, and as Treasurer from December 2017 to July 2021. Prior to joining Constellation Pharmaceuticals, Ms. Reeve served as Corporate Controller of PAREXEL International, a biopharmaceutical ... Read More
19
Sep2022
Dr. Dalal has served on Aerpio’s board of directors since November 2011, continuing in the role after Aerpio merged with Aadi in August 2021. Since August 2016, Dr. Dalal has been working at Acuta Capital. From 2006 to 2016, Dr. Dalal was the Managing Director of Kearny Venture Partners. He ... Read More
17
Sep2022
Dr. Aghazadeh has served on the Company’s board of directors since August of 2021 and is currently the Managing Partner and Portfolio Manager of Avoro Capital Advisors, a global life sciences investment firm with a focus on supporting emerging biotechnology companies, which he joined in July 2011. From March 2017 ... Read More
15
Sep2022
11
Sep2022
Mr. Kwon brings 13 years of biotech industry experience focused on business development and commercial strategy in oncology and has spent 11 years as a strategy consultant working with top biopharma companies. He was originally trained as a cancer biologist and has held positions as a Research Scientist at Memorial ... Read More
05
Sep2022
Mr. Ball serves as Aadi’s Chief Quality Officer and SVP Manufacturing Operations, bringing 25 years of experience leading quality, manufacturing and supply chain teams in healthcare regulated industries. Most recently, Mr. Ball served as the CQO and SVP Operations at Intercept Pharmaceuticals, where he oversaw commercial product and prepared the ... Read More
03
Sep2022
Mr. Rodin joined Aadi in February 2022 as SVP and General Counsel. He was most recently the Executive Vice President and General Counsel of The Medicines Company, which was acquired by Novartis for $9.7B in January 2020. During his 13-year tenure at The Medicines Company, Steve led or ... Read More